Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2013, Diamond Biofund Inc. is a biotechnology investment firm based in Taiwan. It is the first publicly listed sustainable biotech venture capital firm in the country, focusing on enhancing governance, technology development, and business growth for its portfolio companies. The firm manages investments across various stages, including pre-seed, seed, and Series A.
Diamond Biofund specializes in biotechnology and medical sectors, targeting global opportunities in new drug development, advanced medical devices, and agricultural biotechnology. The firm invests in early-stage companies, providing capital along with strategic support in research and development, finance, and corporate governance.
Diamond Biofund has invested in over 20 biotechnology startups, including Chia Tai Tianqing Pharmaceutical Group, known for drug development; EyeYon Medical Ltd., which specializes in innovative medical technologies; Bilayer Therapeutics, focused on therapeutic solutions; Rejuvenate Bio Inc., working on health and wellness biotechnology; and Kendall Capital Partners, providing financial services in the biotech sector.
Submit your pitch through their form at diamondbiofund.com.
Yes, Diamond Biofund often leads investment rounds, particularly in early-stage biotech companies where they can provide significant strategic support.
The firm is open to follow-on investments, especially for companies that demonstrate strong growth potential and align with their investment thesis.
Specific fund size details are not disclosed, but the firm has a history of investing in over 20 companies since its inception.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.